Drug intelligence / Profile preview

stevioside

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Stevioside is a natural glycoside extracted from the leaves of the Stevia rebaudiana plant. It is primarily used as a high-intensity, non-caloric sweetener—about 250–300 times sweeter than sucrose—and is widely incorporated into food and beverage products as an alternative to sugar[3][7]. Beyond its sweetening properties, stevioside has been studied for potential therapeutic effects including anti-hyperglycemic (blood glucose lowering), antihypertensive (blood pressure lowering), anti-inflammatory, anti-tumor, diuretic, immunomodulatory, and anti-diarrheal actions[3][5][8]. Its hypoglycemic effect appears to be mediated by stimulating insulin secretion and increasing insulin sensitivity through mechanisms such as upregulation of GLUT-4 synthesis and inhibition of phosphoenol pyruvate carboxy kinase gene expression in the liver[5][6]. The antihypertensive effect may involve vasorelaxation via inhibition of calcium influx into blood vessels; however, this requires higher doses than those typically consumed in foods[1][5]. Stevioside’s pharmacological effects are most pronounced when blood glucose or blood pressure levels are elevated above normal ranges. It is considered safe within established daily intake limits but questions about chemical purity remain for some preparations. The U.S. FDA recognizes certain purified forms as generally recognized as safe (GRAS) for use in foods[7].

Other names
stevia glycosidestevia extractE960aE-960aE 960a
02

Targets

SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)INSR (Insulin receptor)RELA (Nuclear Factor Kappa B Subunit p65)PPARG (Peroxisome proliferator-activated receptor gamma)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CaV (Voltage-gated calcium channel protein complex)PEPCK (Phosphoenolpyruvate carboxykinase 1)

Beyond the preview

Go deeper on stevioside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on stevioside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call